WallStreetZenWallStreetZen

NASDAQ: INDP
Indaptus Therapeutics Inc Earnings & Revenue

INDP earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$15.1M
Current Profit Margin
0%

INDP Return on Equity

Current Company
-75.6%
Current Industry
15.4%
Current Market
-8.4%
INDP's Return on Equity (-75.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when INDP announces earnings.

INDP Return on Assets

Current Company
-67.1%
Current Industry
2.2%
INDP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

INDP Return on Capital Employed

Current Company
-97.72%
Current Industry
17.7%
INDP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INDP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
INDP$0.00-$15.08M-$15.08MN/AN/A
ONTX$226.00k-$20.17M-$20.18M-29.65%N/A
PMCB$0.00-$1.28M-$6.65MN/AN/A
PIRS$47.36M-$25.47M-$28.06M+2.26%N/A
SYBX$708.00k-$53.99M-$59.44M-22.42%N/A

Indaptus Therapeutics Earnings & Revenue FAQ

What were INDP's earnings last quarter?

On Invalid Date, Indaptus Therapeutics (NASDAQ: INDP) reported Q3 2023 earnings per share (EPS) of -$0.47, up 11.9% year over year. Total Indaptus Therapeutics earnings for the quarter were -$3.92 million. In the same quarter last year, Indaptus Therapeutics's earnings per share (EPS) was -$0.42.

If you're new to stock investing, here's how to buy Indaptus Therapeutics stock.

What was INDP's earnings growth in the past year?

As of Q1 2024, Indaptus Therapeutics's earnings has grown year over year. Indaptus Therapeutics's earnings in the past year totalled -$15.08 million.

What was INDP's revenue last quarter?

On Invalid Date, Indaptus Therapeutics (NASDAQ: INDP) reported Q3 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Indaptus Therapeutics's revenue was $0.00.

What was INDP's revenue growth in the past year?

As of Q1 2024, Indaptus Therapeutics's revenue has grown null year over year. Indaptus Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.